MTOR and neoplasm: Unfortunately, resistance to mTOR inhibitors is a common phenomenon and disease stabilization is mainly responsible for the improvement in progressive-free survival There are several possible mechanisms for rapamycin resistance and treatment failure, with tumour heterogeneity being one of the possible contributing factors.